Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_assertion type Assertion NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_head.
- NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_assertion description "[Pathologically, high circulating levels of FGF23 result in hypophosphatemia, decreased production of 1,25(OH)(2)D, elevated parathyroid hormone and rickets/osteomalacia in patients with functioning kidneys, whereas low levels are associated with tumoral calcinosis, hyperphosphatemia and elevated 1,25(OH)(2)D. In addition, patients with chronic kidney disease (CKD) exhibit marked elevations of circulating FGF23.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_provenance.
- NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_assertion evidence source_evidence_literature NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_provenance.
- NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_assertion SIO_000772 17635819 NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_provenance.
- NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_assertion wasDerivedFrom befree-20150227 NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_provenance.
- NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_assertion wasGeneratedBy ECO_0000203 NP655999.RA6Ht4TGE4vE5wPxoJ31ClTLn7_x37TKps-cCaNgIKlDY130_provenance.